{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-008229","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.052554+00:00","generated_at":"2026-06-06T15:04:29.543149+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Quoin Pharma enters $8M equity purchase agreement with Alumni Capital, with $4M minimum purchase commitment","bullets":["Agreement allows Quoin to sell up to $8M of ADSs to Alumni Capital at discounts of 2% to 10% to market.","Minimum purchase of $4M required during the 90-day commitment period, extendable by 90 days.","Per-purchase limit typically $500k; floor price $1.00; commitment fee up to $240k in ADSs.","Shareholder approval must be obtained by April 30, 2024; else Quoin may terminate agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-008229","json":"https://secwatch.observer/filing/0001104659-24-008229.json","markdown":"https://secwatch.observer/filing/0001104659-24-008229.md","text":"https://secwatch.observer/filing/0001104659-24-008229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/0001104659-24-008229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/tm244426d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:04:29.543149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"50b642f044c92b1200533bd13c70afe717001ece","claim":"Quoin Pharmaceuticals, Ltd. entered into Purchase Agreement with Alumni Capital LP valued at up to $8,000,000 (effective 2024-01-25).","evidence_excerpt":"On January 25, 2024, Quoin Pharmaceuticals Ltd. (the “Company” or “we”) entered into a Purchase Agreement (the “Purchase Agreement”) with Alumni Capital LP (“Alumni”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/0001104659-24-008229-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Alumni Capital LP"},{"label":"Value","value":"up to $8,000,000"},{"label":"Effective","value":"2024-01-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}